2014
DOI: 10.1016/s1388-2457(14)50346-x
|View full text |Cite
|
Sign up to set email alerts
|

P212: Clinical spectrum of sensory ganglionopathy in eight patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…13 Another study treated SNN with IVIG and/or high-dose steroids, but reported poor responses in 4 of 10 patients, neurological improvements in 5 of 10 patients, and no change in 1 patient. 14 Antoine et al suggested that the optimal therapeutic window for treating acute/subacute inflammatory SNN is within 8 months of disease onset for stabilization and within 2 months of disease onset for symptom improvement. 15 In our case, no treatment was administered for financial reasons and no spontaneous improvements in neurological deficits were observed over 1 year of careful follow-up clinical monitoring.…”
Section: Discussionmentioning
confidence: 99%
“…13 Another study treated SNN with IVIG and/or high-dose steroids, but reported poor responses in 4 of 10 patients, neurological improvements in 5 of 10 patients, and no change in 1 patient. 14 Antoine et al suggested that the optimal therapeutic window for treating acute/subacute inflammatory SNN is within 8 months of disease onset for stabilization and within 2 months of disease onset for symptom improvement. 15 In our case, no treatment was administered for financial reasons and no spontaneous improvements in neurological deficits were observed over 1 year of careful follow-up clinical monitoring.…”
Section: Discussionmentioning
confidence: 99%